Reporting Manager
Madison Avenue International LP
Symbol
INDV
Shares outstanding
125,610,040 shares
Disclosed Ownership
6,280,502 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:57:13 UTC
Date of event
31 Dec 2025
Previous filing
18 Mar 2025

Sponsored

Quoteable Key Fact

"Madison Avenue Partners, LP disclosed 5% ownership in Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) on 31 Dec 2025."

Quick Takeaways

  • Madison Avenue Partners, LP filed SCHEDULE 13G/A for Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV).
  • Disclosed ownership: 5%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 18 Mar 2025.
  • Current filing was accepted on 17 Feb 2026, 16:57.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Madison Avenue International LP 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
Madison Avenue Partners, LP 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
EMAI Management, LLC 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Managing Member
Madison Avenue GP, LLC 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Manager
Caraway Jackson Investments LLC 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Member
Eli Samaha 5% 6,280,502 0 6,280,502 /s/ Eli Samaha ELI SAMAHA